Priscilla L. Yang

Affiliations: 
2021- Microbiology and Immunology Stanford University School of Medicine, Palo Alto, CA, United States 
Area:
Virology Biology, Biochemistry, chemical biology
Google:
"Priscilla Yang"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Li Z, Liu HY, He Z, et al. (2024) Discovery of Potent Degraders of the Dengue Virus Envelope Protein. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2405829
Liu HY, Li Z, Reindl T, et al. (2024) Broad-spectrum activity against mosquito-borne flaviviruses achieved by a targeted protein degradation mechanism. Nature Communications. 15: 5179
Li Z, Liu HY, He Z, et al. (2024) Discovery of Potent Degraders of the Dengue Virus Envelope Protein. Biorxiv : the Preprint Server For Biology
Chakravarty A, Yang PL. (2022) Targeted protein degradation as an antiviral approach. Antiviral Research. 105480
Boytz R, Słabicki M, Ramaswamy S, et al. (2022) Anti-SARS-CoV-2 Activity of Targeted Kinase Inhibitors: Repurposing Clinically Available Drugs for COVID-19 Therapy. Journal of Medical Virology
Liu HY, Yang PL. (2021) Small-Molecule Inhibition of Viral Fusion Glycoproteins. Annual Review of Virology
Yang PL. (2021) Antiviral Therapeutics. Acs Infectious Diseases
de Wispelaere M, Carocci M, Burri DJ, et al. (2020) A broad-spectrum antiviral molecule, QL47, selectively inhibits eukaryotic translation. The Journal of Biological Chemistry. 295: 1694-1703
Weisberg E, Parent A, Yang PL, et al. (2020) Repurposing of Kinase Inhibitors for Treatment of COVID-19. Pharmaceutical Research. 37: 167
Yang PL. (2020) Call for Papers: Antiviral Therapeutics Acs Infectious Diseases
See more...